Healthcare Global Enterprises Limited (HCG) - Net Assets
Based on the latest financial reports, Healthcare Global Enterprises Limited (HCG) has net assets worth Rs9.94 Billion INR (≈ $107.47 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs35.86 Billion ≈ $387.77 Million USD) and total liabilities (Rs25.92 Billion ≈ $280.30 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Healthcare Global Enterprises Limited (HCG) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs9.94 Billion |
| % of Total Assets | 27.71% |
| Annual Growth Rate | 13.11% |
| 5-Year Change | 38.66% |
| 10-Year Change | 115.93% |
| Growth Volatility | 37.05 |
Healthcare Global Enterprises Limited - Net Assets Trend (2011–2025)
This chart illustrates how Healthcare Global Enterprises Limited's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Healthcare Global Enterprises Limited for the complete picture of this company's asset base.
Annual Net Assets for Healthcare Global Enterprises Limited (2011–2025)
The table below shows the annual net assets of Healthcare Global Enterprises Limited from 2011 to 2025. For live valuation and market cap data, see market cap of Healthcare Global Enterprises Limited.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs9.90 Billion ≈ $107.07 Million |
+14.44% |
| 2024-03-31 | Rs8.65 Billion ≈ $93.56 Million |
-0.49% |
| 2023-03-31 | Rs8.69 Billion ≈ $94.02 Million |
-1.62% |
| 2022-03-31 | Rs8.84 Billion ≈ $95.57 Million |
+23.77% |
| 2021-03-31 | Rs7.14 Billion ≈ $77.22 Million |
+70.09% |
| 2020-03-31 | Rs4.20 Billion ≈ $45.40 Million |
-19.61% |
| 2019-03-31 | Rs5.22 Billion ≈ $56.47 Million |
-9.81% |
| 2018-03-31 | Rs5.79 Billion ≈ $62.62 Million |
+18.14% |
| 2017-03-31 | Rs4.90 Billion ≈ $53.00 Million |
+6.89% |
| 2016-03-31 | Rs4.59 Billion ≈ $49.59 Million |
+120.97% |
| 2015-03-31 | Rs2.08 Billion ≈ $22.44 Million |
-26.44% |
| 2014-03-31 | Rs2.82 Billion ≈ $30.51 Million |
-4.70% |
| 2013-03-31 | Rs2.96 Billion ≈ $32.01 Million |
+34.87% |
| 2012-03-31 | Rs2.19 Billion ≈ $23.73 Million |
+24.38% |
| 2011-03-31 | Rs1.76 Billion ≈ $19.08 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Healthcare Global Enterprises Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4577.9% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs1.39 Billion | 15.11% |
| Other Comprehensive Income | Rs202.82 Million | 2.20% |
| Other Components | Rs11.72 Billion | 127.05% |
| Total Equity | Rs9.22 Billion | 100.00% |
Healthcare Global Enterprises Limited Competitors by Market Cap
The table below lists competitors of Healthcare Global Enterprises Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ton Yi Industrial Corp
TW:9907
|
$873.14 Million |
|
Anhui Estone Materials Technology Co Ltd
SHG:688733
|
$874.08 Million |
|
Eletromidia S.A
SA:ELMD3
|
$874.17 Million |
|
Chengdu M&S Electronics Technology Co Ltd
SHG:688311
|
$874.58 Million |
|
Shandong New Beiyang Information Technology Co Ltd
SHE:002376
|
$872.98 Million |
|
Keeson Technology Corp Ltd
SHG:603610
|
$872.95 Million |
|
Nanjing Kangni Mechanical & Electrical Co Ltd
SHG:603111
|
$872.90 Million |
|
Tianma Bearing Group Co Ltd
SHE:002122
|
$872.79 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Healthcare Global Enterprises Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 8,257,800,000 to 9,224,500,000, a change of 966,700,000 (11.7%).
- Net income of 444,100,000 contributed positively to equity growth.
- Share repurchases of 15,600,000 reduced equity.
- New share issuances of 15,600,000 increased equity.
- Other comprehensive income increased equity by 64,170,000.
- Other factors increased equity by 458,430,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs444.10 Million | +4.81% |
| Share Repurchases | Rs15.60 Million | -0.17% |
| Share Issuances | Rs15.60 Million | +0.17% |
| Other Comprehensive Income | Rs64.17 Million | +0.7% |
| Other Changes | Rs458.43 Million | +4.97% |
| Total Change | Rs- | 11.71% |
Book Value vs Market Value Analysis
This analysis compares Healthcare Global Enterprises Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 8.78x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 28.26x to 8.78x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-03-31 | Rs20.26 | Rs572.55 | x |
| 2012-03-31 | Rs25.02 | Rs572.55 | x |
| 2013-03-31 | Rs46.95 | Rs572.55 | x |
| 2014-03-31 | Rs38.41 | Rs572.55 | x |
| 2015-03-31 | Rs24.86 | Rs572.55 | x |
| 2016-03-31 | Rs58.44 | Rs572.55 | x |
| 2017-03-31 | Rs50.80 | Rs572.55 | x |
| 2018-03-31 | Rs59.75 | Rs572.55 | x |
| 2019-03-31 | Rs54.10 | Rs572.55 | x |
| 2020-03-31 | Rs43.06 | Rs572.55 | x |
| 2021-03-31 | Rs61.34 | Rs572.55 | x |
| 2022-03-31 | Rs64.38 | Rs572.55 | x |
| 2023-03-31 | Rs61.59 | Rs572.55 | x |
| 2024-03-31 | Rs58.81 | Rs572.55 | x |
| 2025-03-31 | Rs65.22 | Rs572.55 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Healthcare Global Enterprises Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.81%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.00%
- • Asset Turnover: 0.63x
- • Equity Multiplier: 3.84x
- Recent ROE (4.81%) is above the historical average (-3.10%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 3.68% | 2.94% | 0.55x | 2.27x | Rs-108.06 Million |
| 2012 | -1.58% | -1.25% | 0.48x | 2.61x | Rs-244.54 Million |
| 2013 | -3.71% | -3.11% | 0.48x | 2.50x | Rs-388.54 Million |
| 2014 | -13.48% | -7.88% | 0.66x | 2.61x | Rs-619.30 Million |
| 2015 | 0.46% | 0.16% | 0.69x | 4.16x | Rs-173.89 Million |
| 2016 | -0.34% | -0.25% | 0.56x | 2.45x | Rs-440.43 Million |
| 2017 | 5.12% | 3.17% | 0.57x | 2.83x | Rs-210.93 Million |
| 2018 | 3.98% | 2.47% | 0.58x | 2.80x | Rs-309.87 Million |
| 2019 | -5.20% | -2.53% | 0.59x | 3.47x | Rs-724.62 Million |
| 2020 | -27.99% | -9.74% | 0.49x | 5.91x | Rs-1.45 Billion |
| 2021 | -27.75% | -19.09% | 0.50x | 2.92x | Rs-2.63 Billion |
| 2022 | 6.17% | 3.84% | 0.63x | 2.55x | Rs-332.96 Million |
| 2023 | 3.41% | 1.73% | 0.73x | 2.69x | Rs-567.04 Million |
| 2024 | 5.83% | 2.52% | 0.71x | 3.28x | Rs-344.23 Million |
| 2025 | 4.81% | 2.00% | 0.63x | 3.84x | Rs-478.35 Million |
Industry Comparison
This section compares Healthcare Global Enterprises Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $20,095,851,333
- Average return on equity (ROE) among peers: 4.95%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Healthcare Global Enterprises Limited (HCG) | Rs9.94 Billion | 3.68% | 2.61x | $873.06 Million |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $25.19 Billion | 8.42% | 0.70x | $11.87 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $31.90 Billion | 8.43% | 1.35x | $3.92 Billion |
| GPT Healthcare Ltd (GPTHEALTH) | $2.48 Billion | 20.14% | 0.55x | $122.84 Million |
| Jupiter Life Line Hospitals Limited (JLHL) | $2.88 Billion | 17.73% | 2.15x | $869.25 Million |
| Krishna Institute of Medical Sciences Limited (KIMS) | $5.67 Billion | -8.43% | 0.98x | $2.89 Billion |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $509.11 Million | -4.42% | 0.10x | $26.73 Million |
| Max Healthcare Institute Limited (MAXHEALTH) | $93.81 Billion | 11.47% | 0.62x | $10.45 Billion |
| Max India Limited (MAXIND) | $4.92 Billion | -11.45% | 0.39x | $88.24 Million |
| Global Health Limited (MEDANTA) | $13.50 Billion | 2.69% | 0.98x | $3.25 Billion |
About Healthcare Global Enterprises Limited
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncol… Read more